Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
02/1995
02/14/1995US5389660 Substituted imidazo-fused 5-membered ring heterocycles as angiotensin II antagonists
02/14/1995US5389659 C-linked pyrazole derivatives
02/14/1995US5389655 Treats angina pectoris
02/14/1995US5389649 Relax vascular smooth muscle
02/14/1995US5389642 Exhibit antagonistic properties toward angiotensin(II); useful for treatment of hypertensioni, aldosteronism, cardiac insufficiency, increased intraocular pressure and disorders of the central nervous system
02/14/1995US5389634 Imidazole derivatives having angiotensin II receptor antagonistic activity
02/14/1995US5389614 Anticoagulants
02/14/1995US5389610 Carboxyalkylcarbonyl aminoacid endopeptidase inhibitors
02/14/1995US5389370 Active component concentrates and new active component combinations from ginkgo biloba leaves, their method of preparation and pharmaceuticals containing the active component concentrates or the active component combinations
02/14/1995CA2130020A1 Sulphonylbenzyl-substituted benzimidazoles, a process for their preparation and their use in medicaments
02/14/1995CA1334382C Osmotic continuous dispensing oral delivery system containing a pharmaceutically acceptable active agent having improved core membrane adhesion properties
02/12/1995CA2129701A1 Medicaments containing 1-thiocarbamoyl-5-hydroxy-pyrazoles and their use as agents for combating septic shock
02/09/1995WO1995004142A2 Antisense oligonucleotide inhibition of vascular endothelial growth factor expression
02/09/1995WO1995004056A1 Heterocyclic amines having central nervous system activity
02/09/1995WO1995004053A1 Urea and thiourea derivatives and process for their preparation
02/09/1995WO1995004052A1 Methylguanidine derivatives, methods for preparing same and compositions containing said derivatives
02/09/1995WO1995004048A1 Benzoxazinones and benzothiazinones endowed with therapeutic activity
02/09/1995WO1995004047A1 2-benzoheterocyclyloxy or thiopropanolamine derivatives with adreno receptor agonist activity
02/09/1995WO1995004033A1 Succinamide derivatives, processes for their preparation and their use as gelatinase and collagenase inhibitors
02/09/1995WO1995004028A1 Indane and tetrahydronaphthalene derivatives as calcium channel antagonists
02/09/1995WO1995004027A1 Aminoindanes and related compounds useful as calcium-channel antagonists
02/09/1995WO1995003822A2 Use of relaxin as therapeutic or preventing agent
02/09/1995WO1995003816A1 Compositions of crataegus species, medicaments and their use for preventing sudden death due to cardiac arrest and reperfusion-caused cardiovascular lesions
02/09/1995WO1995003797A1 Method to inhibit restenosis
02/09/1995WO1995003795A1 Method of treating atherosclerosis or restenosis using microtubule stabilizing agent
02/09/1995WO1995003764A1 Skin patches and methods for providing testosterone
02/09/1995WO1995003753A1 Medicinal for protection from neurological damage
02/09/1995DE4428025A1 Inhibitoren der Acyl-Enzym-A-Cholesterin-O-Acyl-Transferase mit therapeutischer Wirksamkeit, ihre Verwendung und sie enthaltende pharmazeutische Zusammensetzungen Inhibitors of acyl-enzyme A: cholesterol O-acyl transferase with therapeutic efficacy, their use and pharmaceutical compositions containing them
02/09/1995CA2168257A1 Aminoindanes and related compounds useful as calcium-channel antagonists
02/09/1995CA2168099A1 Benzoxazinones and benzothiazinones endowed with therapeutic activity
02/09/1995CA2168043A1 Method to inhibit restenosis
02/09/1995CA2167680A1 Antisense oligonucleotide inhibition of vascular endothelial growth factor expression
02/09/1995CA2145515A1 Use of relaxin as therapeutic or preventing agent
02/08/1995EP0637592A1 Processes of producing amylase inhibitors
02/08/1995EP0637583A1 1-Aryloxy-3-alkylamino-2-propanol nitrate esters, the use thereof and corresponding pharmaceutical composition
02/08/1995EP0637315A1 Adenosine derivatives having a 2? agonist activity
02/08/1995EP0637308A1 Benzodiazepine derivatives, compositions containing them and their use in therapy
02/08/1995EP0637307A1 Imidazole, triazole and tetrazole derivatives
02/08/1995EP0637303A1 N-aryloxy(thio)alkyl-azacycloalkanes useful as calcium channel antagonists
02/08/1995EP0637237A1 Calcium receptor-active molecules
02/08/1995EP0637203A1 Regulation of the immune system
02/08/1995CN1098414A Novel triazolopyrimidones, their preparation and use
02/08/1995CN1098411A Oxazolidinedione derivatives, their production and use
02/08/1995CN1098406A New benzamide derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
02/07/1995US5387709 Bronchodilator agents, anticoagulants, vasodilation
02/07/1995US5387604 Useful in treatment of anxiety, depression, migraine, stroke and hypertension
02/07/1995US5387603 1,5,7-trisubstituted indoline compounds and salts thereof
02/07/1995US5387601 Medicament
02/07/1995US5387592 Angiotensin converting enzyme inhibitors, calcium channel blockers, diuretics and adrenergic blocking agents
02/07/1995US5387591 Pyrrolidine compounds
02/07/1995US5387582 Vitamin D analogues
02/06/1995CA2129483A1 Bicyclic derivatives of imidazole, process for their preparation, new intermediate compounds thus obtained, their application as medicaments, and pharmaceutical compositions containing them
02/06/1995CA2129374A1 Carbonamides, pharmaceutical compositions containing these compounds and processes for their preparation
02/04/1995CA2129301A1 Benzo-fused heterocyclic compounds with a 5-membered ring, process for their preparation, their use as medicaments, their use as diagnostic agents, and medicaments containing them
02/02/1995WO1995003324A1 Oncoprotein protein kinase
02/02/1995WO1995003323A1 Oncoprotein protein kinase
02/02/1995WO1995003313A1 Novel silylated benzylamine derivatives, salts thereof, methods of manufacture and pharmaceutical compositions containing them
02/02/1995WO1995003305A1 Fused benzazepine derivative and pharmaceutical composition containing the same
02/02/1995WO1995003304A1 Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines
02/02/1995WO1995003301A1 Azalicyclooctane derivatives as anti-arrhythmic agents
02/02/1995WO1995003298A1 BENZIMIDAZOLE DERIVATIVES USEFUL AS DOPAMINE RECEPTOR ANTAGONIST, 5-HT RECEPTOR AGONIST OR α1 RECEPTOR ANTAGONIST
02/02/1995WO1995003295A1 Endothelin antagonists
02/02/1995WO1995003292A1 Heteroaryl cycloalkenyl hydroxyureas
02/02/1995WO1995003273A1 Vitamin d analogues
02/02/1995WO1995003061A1 Preparation for improving the blood supply containing hard magnetic particles
02/02/1995WO1995003036A1 Anti-angiogenic compositions and methods of use
02/02/1995CA2472404A1 Combination of stent and anti-angiogenic factor
02/02/1995CA2468375A1 Anti-angiogenic compositions, uses and methods
02/02/1995CA2167837A1 Vitamin d analogues
02/02/1995CA2167821A1 New silylated benzylamine derivatives and their salts; process for producing the same and pharmaceutical compositions containing them
02/02/1995CA2167410A1 Endothelin antagonists
02/02/1995CA2167302A1 Oncoprotein protein kinase
02/01/1995EP0636626A1 Pyrazolopyrimidine Derivatives
02/01/1995EP0636625A2 Tricyclic diazepine vasopressin antagonists and oxytocin antagonists
02/01/1995EP0636623A1 Indole derivatives as 5-HT1- like agonists
02/01/1995EP0636619A1 Tricyclic heterocyclic compound
02/01/1995EP0636614A1 Derivatives of 1-benzenesulfonyl-1,3-dihydro-2H-benzimidazol-2-one, their preparation and pharmaceutical compositions containing them
02/01/1995EP0636611A2 Optically active 1,4-dihydropyridine derivatives and process for preparing the same
02/01/1995EP0636609A1 1-Benzyl-1,3-dihydro-indol-2-one derivatives, their preparation, the pharmaceutical compositions containing them
02/01/1995EP0636608A1 Derivatives of 1-benzenesulfonyl-1,3-dihydro-indol-2-one, their preparation and pharmaceutical compositions containing them
02/01/1995EP0636367A1 Use of phenylalkylamines for producing cholesterol lowering agents
02/01/1995EP0636144A1 Alpha-aminoboronic acid peptides and their use as elastase inhibitors
02/01/1995EP0636142A1 Lactam peptides having hle inhibiting activity
02/01/1995EP0636140A1 Partially modified and retro-inverted tetrapeptides analogues of c-reactive protein fragments.
02/01/1995EP0636128A1 Piperazinocarbonylcarbostyrils as peripheral vasodilators
02/01/1995EP0636127A1 Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity
02/01/1995EP0636124A1 3,4-dihydro-2h-1,2,4-benzothiadiazine-1,1-dioxide-3-carboxylic acid derivatives, preparation thereof and drugs containing same
02/01/1995EP0636119A1 Phenyl substituted cycloalkyl hydroxyurea derivatives which inhibit lipoxygenase
02/01/1995EP0556308B1 Oxysulfonyl urea acat inhibitors
02/01/1995EP0528997B1 Disulfide derivatives of mercaptoacylamino acids
02/01/1995EP0495776B1 Stabilized nitric oxide-primary amine complexes useful as cardiovascular agents
02/01/1995EP0404797B1 1H/3H-[4-(N,N-CYCLOALKYL AND/OR BRANCHED-ALKYLCARBOXAMIDO) -BENZYL]IMIDAZO[4,5-c]PYRIDINES AS PAF ANTAGONISTS
02/01/1995CN1098099A Hexahydronaphthalene ester derivatives, their preparation and their therapeutic uses
02/01/1995CN1098098A 哌嗪衍生物 Piperazine derivatives
01/1995
01/31/1995US5385947 Octahydrophenanthrene derivatives
01/31/1995US5385937 Preventing peroxide generation from mercaptan groups and endothelial injury
01/31/1995US5385935 Method for the inhibition of restenosis associated with coronary intervention
01/31/1995US5385932 Anticholesterol, antilipemic agents
01/31/1995US5385922 Thiazolidine derivatives
01/31/1995US5385921 Treatment for neurodegeneration, alzheimer's disease, huntington's chorea; antihypoxic agents, antiischemic agents